David Gottlieb

Professor David Gottlieb is a Professor of Haematology at the University of Sydney, affiliated with the Westmead Clinical School and The Westmead Institute for Medical Research. His primary role includes clinical leadership as a senior physician on the Westmead Hospital Blood and Marrow Transplant Unit and Medical Director of the Sydney Cellular Therapies Laboratory. He has over 25 years of expertise in clinical stem cell transplantation and cell/gene therapy.

Research focuses on immune system modulation post-transplant, particularly reducing infection recurrence and malignancy relapse. He leads clinical trials using donor-derived T-cells to restore immunity. Notable contributions include advancements in CMV management, T-cell engineering for fungal infections, and adoptive immunotherapy strategies.

Publications span 200+ articles, emphasizing translational research in hematological malignancies, viral reactivation, and stem cell transplantation outcomes. His work bridges clinical practice and innovation in cellular therapies, addressing critical gaps in transplant-related infections and immune recovery.

Grants and collaborations support his research, though specific funding details are not detailed here. He mentors students like Deekshitha DHULIPATI in cutting-edge projects. His lab’s innovations aim to improve transplant patient survival and reduce complications through targeted immune interventions.